Eli Lilly’s Alzheimer’s drug shows promise in slowing cognitive decline
On July 17, Eli Lilly announced positive results from clinical trials of donanemab, the company’s candidate for the treatment of Alzheimer’s disease. The drug […]
Eli Lilly’s Alzheimer’s drug shows promise in slowing cognitive decline Read More »